CEP55 and gallbladder cancer: Our work not only reveals the previously unrecognized mechanism of CEP55 in the pathogenesis of gallbladder cancer but also shows the possibility for CEP55 to be a promising marker and target to be used in the treatment of GBC and improve the survival rate of patients with GBC, which provides an experimental basis for designing effective targeted therapy drugs for gallbladder cancer.